Genetic defects in the cell's 'waste disposal system' linked to Parkinson's disease

November 14, 2017, Baylor College of Medicine
Immunohistochemistry for alpha-synuclein showing positive staining (brown) of an intraneural Lewy-body in the Substantia nigra in Parkinson's disease. Credit: Wikipedia

An international study has shed new light on the genetic factors associated with Parkinson's disease, pointing at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of this common neurodegenerative disorder. The study appears in the journal Brain.

"In recent years, defects in the glucocerebrosidase (GBA) gene have been identified as significant risk factors for Parkinson's disease. Deficiencies in this gene also are known to cause Gaucher disease, a ," said first author Dr. Laurie Robak, instructor of molecular and human genetics at Baylor College of Medicine.

The lysosomes are sac-shaped structures inside all cells that are in charge of clearing the waste produced by the cells. The sacs contain enzymes that degrade cellular waste into its constituent components, which the cell can recycle or discard. When lysosomes fail and cellular waste accumulates, disease follows. Gaucher disease is one of about 50 lysosomal storage disorders.

"Individuals with Gaucher disease can have family members with Parkinson's disease," Robak said. "People who carry one defective copy of the GBA gene have a 5- to 8-fold increase in the risk of having Parkinson's disease later in life. In addition, another gene called SMPD1 related to lysosome storage disorders is emerging as a new risk factor for Parkinson's disease."

In this study, the researchers investigated whether changes in lysosome storage disorder in general could be linked to risk for Parkinson's disease. They compiled a list of 54 genes involved in lysosome storage disorders and determined whether a population with Parkinson's disease was enriched for defective forms of these genes.

Genetics links pediatric condition to risk for a disease that usually affects adults

Lysosomal storage disorders are predominantly diagnosed in children. Thanks to the combined expertise of adult neurologists specializing in Parkinson's disease and both pediatricians and geneticists focusing on childhood lysosomal disorders, the research team was able to make a connection between childhood conditions and the risk for Parkinson's disease later in life.

"We studied the largest Parkinson's disease genetic dataset currently available and found that, although each of the damaging mutations within these genes is individually uncommon, they are common as a group within the Parkinson's cohort," said corresponding authors Dr. Joshua Shulman, assistant professor of neurology, neuroscience and molecular and human genetics at Baylor College of Medicine and investigator at the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital.

The researchers found at least one of the damaging mutations in more than half of the cohort. Twenty percent carry more than one damaging mutation.

"Although more research remains to be done, these data suggest the interesting possibility that damage to the lysosome might be at the core of Parkinson's disease," Shulman said. "It might be possible that Parkinson's disease and lysosomal have similar fundamental biological mechanisms."

"Better understanding the genetics of Parkinson's disease is important because it can lead to improved diagnosis, more insights on how the develops and progresses and perhaps suggest new therapies," Robak said.

Explore further: Rare genetic condition may provide insights on Parkinson's and other late-onset diseases

More information: Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease. Brain, awx285, doi.org/10.1093/brain/awx285

Related Stories

Rare genetic condition may provide insights on Parkinson's and other late-onset diseases

September 19, 2016
A new article suggests that an enzyme deficiency seen in the lysosomal storage disorder Krabbe's disease may point to new mechanisms underlying certain late-onset neurodegenerative diseases such as Parkinson's disease.

Granulins are brain treasure, not trash

August 14, 2017
Emory University School of Medicine researchers have developed tools that enable them to detect small proteins called granulins for the first time inside cells. Granulins are of interest to neuroscientists because mutations ...

Genetic variants linked to higher BMI may be protective against Parkinson disease

June 13, 2017
Genetic variants linked to higher body mass index (BMI) are associated with lower risk of Parkinson disease, according to a study published by Nicholas Wood and colleagues from the University College London, UK, in PLOS Medicine.

Rare genetic disorder provides unique insight into Parkinson's disease

June 23, 2011
Massachusetts General Hospital investigators appear to have found the mechanism behind a previously reported link between the rare genetic condition Gaucher disease and the common neurodegenerative disorder Parkinson's disease. ...

Team finds that drug used for another disease slows progression of Parkinson's

October 8, 2014
A new study from UCLA found that a drug being evaluated to treat an entirely different disorder helped slow the progression of Parkinson's disease in mice.

Breakthrough in understanding Parkinson's disease

August 29, 2016
Research from The University of Queensland could lead to a new treatment for Parkinson's disease, with future potential applications to nearly 50 other disorders.

Recommended for you

Protein levels in spinal fluid correlate to posture and gait difficulty in Parkinson's

February 21, 2018
Levels of a protein found in the brain called alpha-synuclein (α-syn) are significantly lower than normal in cerebrospinal fluid collected in Parkinson's disease patients suffering from postural instability and gait difficulty, ...

New method maps the dopamine system in Parkinson's patients

February 14, 2018
With the aid of a PET camera, researchers from Karolinska Institutet in Sweden have developed a new method for investigating the dopamine system in the brains of patients suffering from Parkinson's disease. The method measures ...

Mechanism behind common Parkinson's mutation discovered

February 5, 2018
Northwestern Medicine investigators have discovered how a gene mutation results in buildup of a toxic compound known to cause Parkinson's disease symptoms, defining for the first time the mechanism underlying that aspect ...

Tactic for controlling motor symptoms of advanced Parkinson's disease

January 25, 2018
Standard drug treatment for Parkinson's disease can over time induce motor complications that reduce the effectiveness of restoring mobility. These complications include abnormal involuntary movements known as dyskinesias. ...

A new therapeutic avenue for Parkinson's disease

January 23, 2018
Systemic clearing of senescent astrocytes prevents Parkinson's neuropathology and associated symptoms in a mouse model of sporadic disease, the type implicated in 95% of human cases. Publishing in Cell Reports, researchers ...

Investigators eye new target for treating movement disorders

January 19, 2018
Blocking a nerve-cell receptor in part of the brain that coordinates movement could improve the treatment of Parkinson's disease, dyskinesia and other movement disorders, researchers at Vanderbilt University have reported.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.